2 months ago
GILD
AnalystsJames ShinJames Shin's Stock Forecasts
AnalystsJames Shin
Sectors:
Industries:
Analyst Ranking
Top 30%
#1425 out of 4861 analysts
Average Return
+11.74%
Win Rate
50%5 out of 10
Risk vs Reward
Poor
Good
James Shin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunogen IncIMGN | +111.87% | $14.74 | $31.23 | 2023-11-08 - 2024-02-09 | Strong Buy |
Sutro Biopharma IncSTRO | +94.67% | $2.25 | $4.38 | 2023-11-08 - 2024-11-08 | Strong Buy |
Autolus Therapeutics PLCAUTL | +6.88% | $3.49 | $3.73 | 2023-11-08 - 2024-11-08 | Strong Buy |
Eli Lilly & CoLLY | +4.20% | $806.14 | $839.96 | 2024-11-03 - 2025-04-17 | Strong Buy |
Merck & Co IncMRK | +0.53% | $102.38 | $102.92 | 2023-11-08 - 2024-11-08 | Strong Buy |
James Shin Analyst Color
Get additional color on James Shin's coverage of popular stocks
2 months ago
MRK
6 months ago
LLY
7 months ago
LLY
8 months ago
LLY
a year ago
LLY
James Shin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gilead Sciences IncGILD | 2 | Strong Buy | $120.00 | +14.79% | Upgrades | 2 months ago |
Merck & Co IncMRK | 2 | Hold | $105.00 | +34.62% | Downgrades | 2 months ago |
Eli Lilly & CoLLY | 4 | Strong Buy | $1,015.00 | +20.84% | Maintains | 6 months ago |
Amgen IncAMGN | 2 | Hold | $305.00 | +9.99% | Reiterates | 8 months ago |
Incyte CorpINCY | 2 | Hold | $60.00 | +3.08% | Maintains | 9 months ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $45.00 | -8.59% | Maintains | 9 months ago |
Legend Biotech CorpLEGN | 1 | Strong Buy | $60.00 | +82.93% | Initiates Coverage On | a year ago |
Abbvie IncABBV | 1 | Hold | $150.00 | N/A | Initiates Coverage On | a year ago |
Regeneron Pharmaceuticals IncREGN | 1 | Hold | $800.00 | N/A | Initiates Coverage On | a year ago |
Immunogen IncIMGN | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | a year ago |
Autolus Therapeutics PLCAUTL | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | a year ago |
Sutro Biopharma IncSTRO | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Affimed NvAFMD | 1 | Strong Buy | $70.00 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.